In vitro interaction of high-LET heavy-ion irradiation and chemotherapeutic agents in two cell lines with different radiosensitivities and different p53 status

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 1961-1967

  Takahashi, Takeo ^a   Fukawa, Takeshi ^b   Hirayama, Ryoichi ^b   Yoshida, Yukari ^c   Musha, Atsushi ^a   Furusawa, Yoshiya ^b   Ando, Koichi ^c   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c GUNMA UNIVERSITY HEAVY ION MEDICAL CENTER   (Japan)

Author keywords

Apoptosis; Carbon ion; Chemotherapeutic agent; High LET; p53; Radiosensitivity

Indexed keywords

CARBON; CISPLATIN; ETOPOSIDE; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL MUTANT; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; IRRADIATION; LINEAR ENERGY TRANSFER; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIVITY; RAT; TUMOR CELL LINE; WILD TYPE; X IRRADIATION; YOLK SAC TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBON; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ETOPOSIDE; GENES, P53; HEAVY IONS; LINEAR ENERGY TRANSFER; NEOPLASMS; RADIATION TOLERANCE; RATS;

EID: 77955071419     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Suzuki M, Kase Y, Yamaguchi H, Kanai T and Ando K: Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beam. Int J Radiat Oncol Biol Phys 48: 241-250, 2000.
2. Blakely EA and Kronenberg A: Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness. Radiat Res 150: s126-s145, 1998.
3. Mori E, Takahashi A, Yamakawa N, Kirita T and Ohnishi T: High LET heavy-ion radiation induces p53-independent apoptosis. J Radiat Res 50: 37-42, 2008.
4. Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H, Kato S, Yamada S, Yasuda S, Ohno T, Yanagi T, Imai R, Kagei K, Kato H, Hara R, Hasegawa A, Nakajima M, Sugane N, Tamaki N, Takagi R, Kandatsu S, Yoshikawa K, Kishimoto R and Miyamoto T: Clinical results of carbon ion radiotherapy at NIRS. Radiat Res 48: A1-13, 2007.
5. Mitsuhashi N, Takahashi T, Nozaki M, Matsumoto H, Sakurai H, Takahashi M and Niibe H: Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential lymphatic metastasis. Jpn J Cancer Res 84: 1287-1291, 1993.
6. Mitsuhashi N, Takahashi T, Sakurai H, Nozaki M, Akimoto T, Hasegawa M, Saito Y, Matsumoto H, Higuchi K, Maebayashi K and Niibe H: A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumor cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis. Int J Radiat Biol 69: 329-336, 1996.
7. Maebayashi K, Mitsuhashi N, Takahashi T, Sakurai H and Niibe H: p53 Mutation decreased radiosensitivity in rat yolk sac tumor cell lines. Int J Radiat Oncol Biol Phys 44: 677-682, 1999.
8. Nakamoto S, Mitsuhashi N, Takahashi T, Sakurai H and Niibe H: An interaction of cisplatin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Int J Radiat Biol 70: 747-753, 1996.
9. Takahashi T, Mitsuhashi N, Akimoto T, Matsumoto H, Ishikawa H, Saito Y and Niibe H: Interaction of radiation and etoposide on two cell lines with different radiosensitivities in vitro. Anticancer Res 23: 3459-3464, 2003.
10. Kanai T, Furusawa Y, Fukutsu K, Itsukaichi H, Eguchi-Kasai K and Ohara H: Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. Radiat Res 147: 78-85, 1997.
11. Aoki M, Furusawa Y and Yamada T: LET dependency of heavy-ion induced apoptosis in V79 cells. J Radiat Res 41: 163-175, 2000.
12. Lee JM and Bernstein A: p53 Mutations increase resistance to ionizing radiation. Proc Natl Acad Sci 90: 5742-5746, 1993.
13. McIlwarth AJ, Vasey PA, Ross GM and Brown R: Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 54: 3718-3722, 1994.
14. Takahashi A, Matsumoto H, Yuki K, Yasumoto J, Kajiwara A, Aoki M, Furusawa Y, Ohnishi K and Ohnishi T: High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. Int J Radiat Oncol Biol Phys 60: 591-597, 2004.
15. Asakawa I, Yoshimura H, Takahashi A, Ohnishi K, Nakagawa H, Ota I, Furusawa Y, Tamamoto T, Ohishi H and Ohnishi T: Radiation-induced growth inhibition in transplanted human tongue carcinomas with different p53 gene status. Anticancer Res 22: 2037-2044, 2002.
16. Takahashi A, Matsumoto H, Furusawa Y, Ohnishi K, Ishioka N and Ohnishi T: Apoptosis induced by high LET radiation is not affected by cellular p53 gene status. Int J Radiat Biol 81: 581-586, 2005.
17. Tsuchida Y, Tsuboi K, Ohyama H, Ohno T, Nose T and Ando K: Cell death induced by high-linear-energy transfer carbon beams in human glioblastoma cell lines. Brain Tumor Pathol 15: 71-76, 1998.
18. Iwadate Y, Mizoe J, Osaka Y, Yamaura A and Tsujii H: High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. Int J Radiat Oncol Biol Phys 50: 803-808, 2001.
19. Takahashi T, Mitsuhashi N, Furuta M, Hasegawa M, Ohno T, Sakurai H, Nakano T and Niibe H: Apoptosis induced by heavy-ion (carbon) irradiation of two human tumours with different radiosensitivities in vivo: relative biological effectiveness (RBE) of carbon beam. Anticancer Res 18: 253-256, 1998.
20. Grégoire V and Baumann M: Molecular mechanisms of interaction between chemotherapy and radiotherapy. In: Basic Clinical Radiology. Joiner M and van der Kogel A (eds.). London: Hodder Arnold pp. 250-251, 2009.
21. Kubota N, Ikegami T, Watai K, Kakehi M and Matsui K: Effect of combined treatment of HeLa S3 cells with radiation and etoposide on cell survival. Nippon Acta Radiol 48: 1276-1282, 1988.
22. Saito T, Shimada Y, Kawanori J and Kamata R: The suppressive effect of etoposide on recovery from sublethal radiation damage in Chinese hamster V79 cells. J Jpn Soc Ther Radiol Oncol 4: 123-130, 1992.
23. Giocanti N, Hennequin C, Balosso J, Mahler M and Favaudon V: DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53: 2105-2111, 1993.
24. Ling CC, Chen CH and Li WX: Apoptosis induced at different dose rates: implication for the shoulder region of cell survival curves. Radiother Oncol 32: 129-136, 1994.
25. 2 delay in human cancer cells. Oncogene 20: 3486-3496, 2001.
26. 2M arrest following DNA damage in human colon cancer cell lines. Jpn J Cancer Res 88: 39-43, 1997.
27. Tuboi K, Moritake T, Tsuchida Y, Tokuuye K, Matsumura A and Ando K: Cell cycle checkpoint and apoptosis induction in glioblastoma cells and fibroblasts irradiated with carbon beam. J Radiat Res 48: 317-325, 2007.
28. 2 phase induced by heavy ions and X-rays. Int J Radiat Biol 58: 781-789, 1990.
29. Simões Magluta EP, Vasconcelos Fda C, Maia RC and Klumb CE: Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells. Cancer Invest 27: 830-835, 2009.
30. Karpinich NO, Tafani M, Schneider T, Russo MA and Farber JL: The course of etoposide-induced apoptosis in Jurkat cells lacking p53 and Bax. J Cell Physiol 208: 55-63, 2006.
31. Ramadan S, Terrinoni A, Catani MV, Sayan AE, Knight RA, Mueller M, Krammer PH, Melino G and Candi E: p73 induces apoptosis dy different mechanisms. Biochem Biophy Res Commun 331: 713-717, 2005.
32. Yang HL, Dong YB, Elliott MJ, Wong SL and McMasters KM: Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells. Cancer Gene Ther 8: 241-251, 2001.